NYSEMKT: IBO
Impact Biomedical Inc Stock Ownership - Who owns Impact Biomedical?

Insider buying vs selling

Have Impact Biomedical Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Dss Inc10% Owner2025-05-2745,400$0.54
$24.52kSell
Dss Inc10% Owner2025-05-22115,600$0.55
$63.46kSell
Dss Inc10% Owner2025-04-04890,800$0.95
$845.37kSell
Heng Fai Ambrose ChanDirector2025-04-04180,000$0.96
$172.80kSell
Heng Fai Ambrose ChanDirector2025-04-03351,555$0.50
$174.02kSell
Heng Fai Ambrose ChanDirector2025-04-03351,631$0.58
$203.59kSell
Heng Fai Ambrose ChanDirector2025-04-03273,286$0.78
$212.89kSell
Heng Fai Ambrose ChanDirector2025-04-02382,427$0.58
$222.95kSell
Heng Fai Ambrose ChanDirector2025-04-02300,000$0.58
$174.30kSell
Heng Fai Ambrose ChanDirector2025-04-02200,000$0.67
$134.80kSell

1 of 4

IBO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IBO insiders and whales buy or sell their stock.

IBO Shareholders

What type of owners hold Impact Biomedical Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Dss Inc16.51%2,011,882$1.37MInsider
Blackrock Inc2.07%252,730$172.36kInstitution
Frank D. Heuszel0.80%97,344$66.39kInsider
Geode Capital Management LLC0.41%49,869$34.01kInstitution
Ubs Group Ag0.33%39,725$27.09kInstitution
Vanguard Group Inc0.27%32,437$22.12kInstitution
Susquehanna International Group LLP0.25%30,824$21.02kInstitution
Two Sigma Investments LP0.19%22,700$15.48kInstitution
State Street Corp0.10%11,797$8.05kInstitution
Stonex Group Inc0.09%10,794$7.36kInstitution

1 of 3

IBO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IBO3.87%17.31%Net Selling
CANF0.02%0.00%
VYNE23.70%76.30%Net SellingNet Selling
CYCN10.87%85.27%Net Selling
ENTO2.06%97.94%Net Selling

Impact Biomedical Stock Ownership FAQ

Who owns Impact Biomedical?

Impact Biomedical (NYSEMKT: IBO) is owned by 3.87% institutional shareholders, 17.31% Impact Biomedical insiders, and 78.82% retail investors. Dss Inc is the largest individual Impact Biomedical shareholder, owning 2.01M shares representing 16.51% of the company. Dss Inc's Impact Biomedical shares are currently valued at $1.27M.

If you're new to stock investing, here's how to buy Impact Biomedical stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.